Lysosomal enzyme tripeptidyl peptidase 1 plays a role in degradation of beta amyloid fibrils
Alzheimers disease (AD) is characterized by the accumulation of amyloid plaques surrounded by microglia. In cell culture, microglia internalize fibrillar {beta}-amyloid but do not degrade it efficiently. Unactivated microglia have a relatively high lysosomal pH, which impairs the activity of lysosomal proteases. Previous studies showed that activation of microglia with macrophage colony stimulating factor decreases lysosomal pH and enhances fibrillar {beta}-amyloid degradation. We investigated the role of the lysosomal protease tripeptidyl peptidase 1 (TPP1) in cell culture and in a mouse model of Alzheimers disease. Increased levels of TPP1 in unactivated microglia enhanced fibrillar {beta}-amyloid degradation. Conversely, reduction of TPP1 led to decreased fibrillar {beta}-amyloid degradation in activated microglia, macrophages, and other cells that degrade fibrillar {beta}-amyloid efficiently. Reduction of TPP1 in an AD model mouse using a gene-targeted hypomorphic Tpp1 allele increased plaque burden. These results suggest that decreased TPP1 potentiates AD pathogenesis and that strategies to increase TPP1 activity may have therapeutic value. Highlights*In microglia, TPP1 is important for the degradation of fibrillar {beta}-amyloid. *Increased TPP1 in microglia results in enhanced fibrillar {beta}-amyloid degradation. *In an AD mouse model, reduction of TPP1 led to increased amyloid plaque deposition.